{"id":118353,"date":"2018-12-28T00:00:00","date_gmt":"2018-12-28T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/report\/m360dd0007-medtech-drug-delivery-devices-market-insights-europe\/"},"modified":"2026-03-31T10:17:45","modified_gmt":"2026-03-31T10:17:45","slug":"m360dd0007-medtech-drug-delivery-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360dd0007-medtech-drug-delivery-devices-market-insights-europe\/","title":{"rendered":"Drug Delivery Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>\n\tThe European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-cost\u00a0generic drug delivery devices will support rising overall sales volumes, which will be further supported by expanding patient populations.<\/p>\n<p>\n\tThis Medtech 360 Report provides comprehensive data and analysis on the current state of the market for drug delivery devices\u00a0in Europe across a 10-year period.<\/p>\n<p class=\"question-statement\">\n\t<strong>The adoption of drug delivery devices varies widely across Europe, based on physician preferences as well as cultural and economic factors<\/strong>.<\/p>\n<p>\n\tWhy do physicians and patients in the countries covered prefer certain devices, and how will this impact drug delivery device adoption over the forecast period?<\/p>\n<p>\n\tHow will device preferences change over the forecast period?<\/p>\n<p class=\"question-statement\">\n\t<strong>Several new drug delivery technologies are in development, including microneedle transdermal patches and subcutaneous implants.<\/strong><\/p>\n<p>\n\tWhat kinds of conditions are these new devices targeting?<\/p>\n<p>\n\tWhich products hold the greatest promise for successful adoption after launch?<\/p>\n<p>\n\tHow will the launch of new products influence <abbr title=\"Average Selling Price\">ASP<\/abbr>s and competitor dynamics?<\/p>\n<p>\n\tWhat considerations must be taken into account for new competitors intending to enter the market?<\/p>\n<p class=\"question-statement\">\n\t<strong>Innovations and product improvements will strongly influence growth in the injection device market.<\/strong><\/p>\n<p>\n\tHow will innovative devices, such as needle-free injection systems and smart devices, contribute to the growth of the injection device market?<\/p>\n<p>\n\tHow will adoption of emerging alternative technologies, such as insulin pumps and closed-loop systems,\u00a0affect injection device sales?<\/p>\n","protected":false},"template":"","class_list":["post-118353","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-drug-delivery-devices","medtech-therapy-area-other-medical-technology","medtech-geography-europe","medtech-date-918"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/118353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/118353\/revisions"}],"predecessor-version":[{"id":289219,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/118353\/revisions\/289219"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=118353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}